# The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes

> **NCT03426085** · PHASE2 · UNKNOWN · sponsor: **Eastern Virginia Medical School** · enrollment: 44 (estimated)

## Conditions studied

- Autonomic Nervous System Diseases
- Sweat Gland Diseases
- Diabetic Neuropathy With Neurologic Complication

## Interventions

- **DRUG:** Liraglutide 6 mg Solution for Injection
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03426085
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2020-04
- **Final completion:** 2020-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03426085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03426085, "The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03426085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*